Lates News

Shanghai Mayor Gong Zheng met with the Chairman of the Board of Directors of Danish Novo Nordisk Company, Lars Fruergaard Jrgensen, today (August 21). Gong Zheng said that Shanghai will continue to enhance the source of scientific and technological innovation in the biopharmaceutical industry, promote the international development of the industry, and accelerate the construction of a globally influential innovative highland in the biopharmaceutical industry. Welcoming world-renowned companies such as Novo Nordisk to actively participate in improving the headquarters capabilities in Shanghai, deeply integrating into local research and development and supply chains, and empowering local enterprises and medical research institutions in Shanghai to assist in the development of the biopharmaceutical industry in Shanghai and achieve win-win cooperation. At the same time, Shanghai welcomes Novo Nordisk to actively participate in the 8th China International Import Expo. Shanghai will continue to create a market-oriented, rule-of-law, and international first-class business environment to provide better conditions for the development of various operating entities. (Shanghai release)